Microvascular and cardiovascular outcomes according to renal function in patients treated with once-weekly exenatide: Insights from the EXSCEL trial - Bethel, MA; Mentz, RJ; Merrill, P (Diabetes Care, 2020)
doi:10.2337/dc19-1065